Navigation Links
Nektar Therapeutics to Present at the 33rd Annual Cowen and Company Healthcare Conference in Boston
Date:3/1/2013

SAN FRANCISCO, March 1, 2013 /PRNewswire/ -- Nektar Therapeutics' (Nasdaq: NKTR) Senior Vice President and Chief Medical Officer, Dr. Robert Medve , is scheduled to present at the 33rd Annual Cowen and Company Healthcare Conference at the Boston Marriott Copley Place on Tuesday, March 5, 2013 at 8:00 a.m. Eastern time.

The presentation will be accessible via a Webcast through a link posted on the Investor Relations, Events Calendar section of the Nektar website http://www.nektar.com. This webcast will be available for replay until April 8, 2013.

About Nektar

Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar has a robust R&D pipeline of potentially high-value therapeutics in pain, oncology and other therapeutic areas. In the area of pain, Nektar has an exclusive worldwide license agreement with AstraZeneca for naloxegol (NKTR-118), an investigational drug candidate, which has completed Phase 3 clinical development as a once- daily, oral tablet for the treatment of opioid-induced constipation. This agreement also includes NKTR-119, an earlier stage development program that is a co-formulation of naloxegol and an opioid. In the proprietary pipeline, NKTR-181, a novel mu-opioid analgesic candidate for chronic pain conditions, is in Phase 2 development in osteoarthritis patients with chronic knee pain. NKTR-192, a novel mu-opioid analgesic in development to treat acute pain is in Phase 1 clinical development. In oncology, etirinotecan pegol (NKTR-102) is being evaluated in a Phase 3 clinical study (the BEACON study) for the treatment of metastatic breast cancer and is also in Phase 2 studies for the treatment of ovarian and colorectal cancers.

'/>"/>
SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
3. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
4. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
5. Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
6. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
7. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
8. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the UBS 2012 Global Life Sciences Conference in New York City
9. Nektar to Announce Financial Results for the Third Quarter of 2012 On Tuesday, November 13, 2012, After Close of U.S.-Based Financial Markets
10. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
11. Nektar To Host Conference Call To Discuss The Positive Phase 3 Clinical Results For Naloxegol
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , Aug. 4, 2015 HeartWare ... innovator of less invasive, miniaturized circulatory support technologies that ... announced that its President and Chief Executive Officer, ... Canaccord Genuity 35th Annual Growth Conference at 8:30 a.m. ... being held August 12-13, 2015 at the InterContinental Boston. ...
(Date:8/4/2015)... Aug. 4, 2015  The Pittsburgh Life Sciences Greenhouse ... announced today that one of its portfolio companies, Medrobotics ... Flex ® Robotic System in the U.S.  ... proud of Medrobotics," said John W. Manzetti , ... very long way since spinning out of The Robotics ...
(Date:8/4/2015)... , Aug. 4, 2015  Intec Pharma Ltd. (the ... company focused on developing drugs based on its proprietary ... its initial public offering in the United ... at a price to the public of $6.00 per ... the ordinary shares are being offered by the Company.  ...
Breaking Medicine Technology:HeartWare Presentation At The Canaccord Genuity 35th Annual Growth Conference To Be Webcast 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 3Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 2Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 3
... CHENGDU, China, Jan. 7, 2011  /PRNewswire-Asia-FirstCall/ -- Tianyin ... ), a pharmaceutical company that specializes in patented ... other pharmaceuticals today announced that the Company,s 2010 ... New York Stock Exchange Conference Room 632 on Monday, ...
... 2011 Athersys, Inc. (Nasdaq: ATHX ) today ... present at Retail Investor Confrences.com. DATE: , January 11, ... will be a live, interactive online event where investors are ... the presentation hall as well as the company,s "virtual trade ...
Cached Medicine Technology:Tianyin Pharmaceutical to Hold 2010 Shareholder Annual Meeting on March 21, 2011 at NYSE 2Athersys to Present Live at Retail Investor Conferences.com on January 11th 2
(Date:8/4/2015)... (PRWEB) , ... August 05, 2015 , ... Renowned review ... According to the latest update, MillionaireMatch.com has been ranked as the best dating service ... while looking for a life companion. It is essential that people find the right ...
(Date:8/4/2015)... ... , ... Statement by Paul Gionfriddo, President and CEO, Mental Health America , ... Act of 2015 by Senators Bill Cassidy and Christopher Murphy. It is ... , “This legislation and H.R. 2646 [The Helping Families in Mental Health ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... it has joined the American Association of Tissue Banks (AATB) as an Affiliate ... its mission “to honor donors, and to save and improve lives by promoting ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... Rhode Island ... center in the George Washington Medical Building on Wake Robin Road in Lincoln, RI. ... Wake Robin office will offer the most extensive out-patient x-ray hours in the state, ...
(Date:8/4/2015)... Los Angeles, California (PRWEB) , ... August 04, ... ... bearing drawer slides to Los Angeles commercial customers. Finding reliable hardware can ... create unfortunate liabilities. When putting an office together or designing a new ...
Breaking Medicine News(10 mins):Health News:BestMillionaireDatingSites.com Publishes Reviews of the Best Dating Sites for Wealthy Singles 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 3Health News:Exsurco Medical Joins AATB as Affiliate Member 2Health News:Rhode Island Medical Imaging Opens Satellite Imaging Center on Wake Robin Road in Lincoln 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 3Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 4
... A new examination of the origin of syphilis supports the ... aboard Christopher Columbus, ships as they sailed home from ... through sexual contact at the time, but adapted to survive ... "Syphilis has been around for 500 years," study co-leader ...
... the tsunami that devastated Japan in March could reach the ... by NOAA scientists. However, they warn there is still a ... where it,s located, where it will go, and when it ... situation on their hands: How do you deal with debris ...
... , WEDNESDAY, Dec. 28 (HealthDay News) -- Regular ... high levels of gluten and could cause problems for people ... made using barely, which contains a form of gluten called ... eliminates gluten or reduces it to very low levels, according ...
... target a single class of proteins and now scientists ... workings of those proteins critical to our health. A ... new results from a team led by Gregory Tall, Ph.D., ... Rochester Medical Center. The work was published recently in ...
... Reporter , TUESDAY, Dec. 27 (HealthDay News) -- Vegan diets ... of eating that exists on the radical fringes of vegetarianism. ... vegan diets a second look, and nutritionists now believe that ... way to live for most people. "Properly planned vegan ...
... Atherosclerosis is a disease of the major arterial blood vessels. ... and stroke. The proinflammatory molecule IL-1 has been linked to ... an antibody specific for IL-1-beta is being studied for its ... attack and stroke). However, a team of researchers led ...
Cached Medicine News:Health News:Columbus Voyage Tied to Syphilis Spread? 2Health News:Debris scatters in the Pacific Ocean, possibly heading to US 2Health News:Debris scatters in the Pacific Ocean, possibly heading to US 3Health News:Scientists fixate on Ric-8 to understand trafficking of popular drug receptor targets 2Health News:The Mainstreaming of Vegan Diets 2Health News:The Mainstreaming of Vegan Diets 3Health News:The Mainstreaming of Vegan Diets 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: